Cleerly Unveils PowerScribe Integration and Lesion-Level Reporting at RSNA 2025
New additions streamline data transfer with lesion details, helping make information more accessible for care teams
heart attack prevention
AHA 2025 Late-Breaking Science: Cleerly’s AI Atherosclerosis Quantification Outperforms Traditional Risk Scoring
New Data from the CONFIRM2 International Registry Shows AI-QCT Improves Prediction of Major Cardiovascular Events from 62% to 75%
TCT 2025 Late-Breaking Science: Quantitative Assessment of Non-Calcified Plaque Volume Drives Risk for Myocardial Infarction and Death
CONFIRM2 Registry Demonstrates Prognostic Value of AI-Based Plaque Characterization Beyond Stenosis Severity
UnitedHealthcare and Cigna Coverage for Cleerly LABS Advanced Plaque Analysis Begins October 1st
Major Payors Embrace AI-Powered Cardiac Imaging, Expanding Access to Advanced Plaque Analysis
